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Methadone and its Rationale in the Treatment 
of Narcotic Dependency* 
W a l t e r J. Cass idy , M D * * 
An effective methadone maintenance pro-
gram must do more than dispense measured 
doses in a well-organized clinic. It should at-
tempt to effect changes in the patient's per-
sonality and coping mechanisms, social situa-
tion, and other conditioning factors which 
maintain his involvement in narcotics. 
'Presented at the First Canadian National 
Methadone Conference, Ottawa, Ontario; 
January, 1973. 
**Formerly Department of Psychiatry. Now in 
practice in Windsor, Ontario. Address reprint 
request to Dr. Cassidy at 2540 Kildare, Wind-
sor, Ontario, Canada. 
/ \ N effective narcotic treatment pro-
gram requires assessment and interven-
t ion along four dimensions. First is the 
user's pre-narcotic dependency person-
ality; secondly, the changes in his per-
sonality and life style, which have re-
sulted f rom interaction between the ef-
fects of the narcotic and the environ-
ment of the user; th i rd ly, the inf luence 
of the condi t ion ing factors which have 
served to make these changes and main-
tain his involvement in narcotic addic-
t i on ; and fourth ly, his changed social 
pattern. ' Most effective narcotic treat-
ment programs include some individual 
and/or group psychotherapy to deal wi th 
the user's personality problems, along 
w i th vocational counsel l ing, support ive 
psychotherapy, and similar endeavors 
that the social worker and rehabil i tation 
worker br ing to bear on the user's social 
problems. The condi t ion ing factors are 
of ten ignored and, at t imes, more unwit-
t ingly dealt w i th than deliberately. By 
significantly affecting the addict ion pat-
tern, I believe that methadone mainte-
nance programs now offer the most ef-
fective broad scale programs for the 
treatment of narcotic dependent per-
sons. 
An alternative rationale for the use of 
methadone was proposed wi th the in-
t roduct ion of large scale methadone 
maintenance treatment by Dole and 
Nyswander, w h o postulated that narcot-
ic dependency is a metabolic disorder.-
Two versions of the biochemical theory 
have been advanced. The first suggests 
that the user has a pre-existing deficit 
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which prevents him f rom feel ing normal. 
He reacts in much the same way as a 
diabetic suddenly exposed to insulin 
feels better. There is very little empirical 
evidence to substantiate this theory. In-
troduct ion to opiates seems to begin 
wi th exposure, oppor tuni ty for use, and 
wil l ingness to try them. LJnfortunately, 
we do not know how many people try 
drugs such as hero in, cont inue regular 
use, stop, or go on to infrequent use. It 
seems fairly clear that most people who 
try it do so, not because they feel ab-
normal in some sense, but out of a spirit 
of adventure or for " thr i l l -seek ing" . 
From available facts, it appears that a 
fairly high propor t ion of people exposed 
in this way to drugs like heroin cont inue 
their usage. It is also interesting to note 
that a very small percentage of people 
exposed to opiates through iatrogenic 
means go on to cont inued abuse of the 
drug, when the condit ions for which 
they were or ig inal ly prescr ibed no 
longer exist. It appears that the att i tude 
wi th which the user approaches his first 
exper imentat ion w i th narcotics, and 
whether the effect of the drug usage is 
euphoria or the relief of a distressing 
condi t ion, are much more relevant to 
cont inued usage of the drug than any 
supposed pre-existing genetic defect. 
The second version of this metabolic 
disorder theory is that permanent de-
rangement of the metabolic system of 
the user occurs upon extended utiliza-
t ion of narcotics. This theory, also, re-
ceives relatively litt le support f rom med-
ical use of narcotics, even though there 
is litt le doubt that wide-spread prescrib-
ing of narcotics, for condit ions which are 
not of great seriousness, results in more 
persons cont inuing to abuse narcotics. 
Similarly, the length of treatment w i th 
narcotics for a chronic condi t ion is posi-
tively correlated wi th the use of narcot-
ics upon terminat ion of medical neces-
sity. Evidence has been advanced by 
Mart in and his associates that cont inued 
narco t i c a d m i n i s t r a t i o n creates a 
physiological disorder that attains for at 
least four to six months after narcotic 
withdrawal.^ '" Physiological dysfunction 
dur ing protracted abstinence has been 
suggested to be related to relapse, and 
studies wi th animals such as rats have 
s imi lar ly shown an associat ion of 
physiological changes wi th relapse.' Sim-
ilar studies wi th humans have suggested 
an association between protracted ab-
stinence and increased responsivity to 
stress."'" Clinical experience similarly 
identifies the symptoms of protracted 
abstinence. The important issue is that 
this physiological disturbance is pro-
tracted as opposed to permanent. This 
suggests that a methadone maintenance 
program wou ld last for specific periods 
of t ime rather than the idea of l i fe-long 
dependency upon the substitute narco-
tic. The theory also fails to explain the 
fact that abstinent ex-addicts wou ld be 
expected to funct ion poorly w i thout a 
narcotic, but this is not proven — in fact, 
many examples to the contrary are 
known. Also, an adequate dosage of 
methadone or other narcotic wou ld be 
expected to eliminate narcotic craving, 
although this seems to be present in var-
ious programs, regardless of the dosage 
of maintenance methadone. Studies by 
Carbutt and Goldst ien, in which the 
dosage varied f rom 40 to 200 mill igrams 
wi thout the patients' knowledge, ap-
peared not to alter their psychological 
state as reported by their desire for 
changes in dosage, or in behavior, as es-
t imated by their actual experimentat ion 
wi th heroin usage whi le on the mainte-
nance methadone program." ' ' ' ' " ' 
The suggestion that methadone's 
major role in the treatment of narcotic 
dependency is in permit t ing the effec-
tive intervent ion in the condi t ion ing fac-
tors which maintain narcotic depend-
ency can be developed more clearly, if 
first we examine the role of condi t ion ing 
factors.' 
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In heroin dependency there is a 
three-stage cycle which usually lasts ap-
proximately six hours. The three stages 
are (1) euphor ia, which can vary f rom a 
pharmacogenic orgasm to a general feel-
ing of wel l -being or relative lack of con-
cern wi th the envi ronment ; (2) normal-
ity, or the drug user's usual state when 
not affected by the other stages; (3) 
wi thdrawal . 
Euphoria 
I 
Normality 
Withdrawal 
] 6 hours 
Figure 1. 
The user may take an inject ion of 
heroin at any point in the cycle. This is 
significant because the relative effects of 
learning may be dependent upon the 
point in the cycle when the drug is 
taken. The more marked the euphoria, 
the stronger the positive reinforcement. 
An injection whi le still in the state of 
euphoria adds only the positive rein-
forcement afforded by the increment. If 
any, in the euphoria. At the user's stage 
of "norma l i t y " the factor of avoidance 
learning comes into significance. As 
withdrawal develops, escape becomes 
the most important factor. The simple 
contiguity of classical condi t ion ing acts 
throughout the cycle. 
Al though condi t ioning factors have 
been generally accepted as important in 
the problem of drug dependency, there 
has been little discussion of how they 
operate. Wickler has stressed the aver-
sive factors, stating that the variables re-
sponsible for relapse of the user after 
withdrawal f rom drug usage are, f irst, 
"the constant reinforcement of drug-
seeking behavior as a result of relieving 
the disturbing and frightening symptoms 
of the abstinent syndrome by means of in-
jection of narcotics; and secondly, con-
ditioned symptoms of the abstinent syn-
drome, precipitated by stimuli, especially 
environmental and interpersonal, that 
have been associated with the activity of 
the user previous to acquiring drugs."" 
I feel the factors of avoidance and es-
cape, although important , are over-
ridden by the positive reinforcement of 
euphoria. In the first place, initial con-
tact wi th heroin is often unpleasant, due 
to low tolerance. In some individuals 
this prevents further involvement. More 
generally, the euphoric effects of the 
drug lure the user back again and again. 
Dur ing this initial phase there is estab-
lished no th i rd stage of wi thdrawal , so 
that the pattern of dependency upon 
heroin is incomplete. However, as the 
user continues taking drugs, withdrawal 
only later assumes its importance in per-
petuating dependency. Similarly, drug 
dependency which develops wi th the 
amphetamines does not involve the fac-
tor of physical wi thdrawal . However, 
once the dependency is f irmly estab-
l ished, it is similarly very dif f icult to 
eradicate. Thus, the initial effects of the 
drug must be the most important in es-
tablishing the pattern of drug use. 
The state of withdrawal is a variable 
amalgam of psychological and physical 
components. According to my clinical 
experience, it is greatly aggravated by 
ant ic ipat ion, which changes an uncom-
fortable state into an agonizing one. This 
fear is a tradit ion of the " j u n k y " . It ap-
pears to hark back to when heroin was of 
a much higher strength and capable of 
greater acute physical distress. The 
present day levels are inconsistent and 
generally weak — consequently, they 
are not generally associated wi th severe 
withdrawal states on a physical basis. 
One can see this effect in vivo in the 
jailed user; he goes through his "co ld 
turkey" withdrawal w i thout marked dis-
tress if he is sure he wi l l get no treat-
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ment. The same user at tempt ing, as he 
often has, this withdrawal outside of jail 
where he could have access to drugs, 
exper iences excruc ia t ing symptoms 
which result in drug-seeking behavior. 
Where no withdrawal syndrome is es-
tabl ished, condi t ioned stimuli (CS) act 
directly to elicit the condi t ioned re-
sponse of d r u g - s e e k i n g behav io r 
(DSB). Once a withdrawal syndrome is 
established, it becomes incorporated 
into the person's behavior pattern, not 
only as a physiological occurrence, but 
also as a condi t ioned response (CR). 
Hence, once heroin dependency is es-
tabl ished, we can depict it as fo l lows: 
CS Maintained by 
CR Euphoria and 
i 
DSB Absence of Dysphoria 
Figure 2. 
The condi t ioned stimuli can be of two 
varieties: first, originally neutral stimuli 
like the sight of a connect ion or the 
smell of a match; second, original aver-
sive stimuli arising f rom intrapsychic and 
interpersonal confl icts. The extent and 
significance of the latter varies widely 
and refers back to the predependency 
personality and, together wi th w i th -
drawal symptoms, provides the dys-
phoric elements in the dependency pat-
t e r n . The w i t h d r a w a l is i n d u c e d 
psychologically rather than physiologi-
cally. However, withdrawal symptoms 
regardless of cause also act as st imul i , 
since they are fo l lowed by an increased 
occurrence of drug-seeking behavior. 
The whole pattern is kept intact by ef-
fects of the drug, euphor ia, and, where 
appropriate, the absence of dysphoria. 
There is a "na tu ra l " experiment bear-
ing on the above discussion. It is gener-
ally well accepted that users in their late 
thirt ies and fort ies, after many years of 
dependency, stop entirely.'^ Now, it 
seems unreasonable to expect that they 
had somehow become mature and so-
cially adept as a result of their depend-
ency. In the out l ine above, the only fac-
tors which significantly vary are the ef-
fects of the drug — dysphoric factors are 
seldom changed. Wi th prolonged use, 
developed tolerance often reaches such 
a point that the euphoria is so decreased 
that the user merely tries to stay "nor -
ma l " and avoid sickness. He is, nonethe-
less, as prone to withdrawal symptoms 
as ever. Stil l, since the drug-seeking 
behavior is no longer reinforced by 
euphor ia, the pattern initiated by this ef-
fect is now capable of ext inct ion. Once 
again this suggests that the positive rein-
forcement of euphoria is of pr ime im-
portance in the maintenance of drug de-
pendency. Where the user quits, the ab-
sence of euphoria is likely to be the only 
significant change. This could be seen 
reasonably as the change permit t ing ex-
t inct ion to occur. 
Methadone's uti l ization in a mainte-
nance program would appear to be jus-
t i f ied over the simple uti l ization of other 
opiates due to two properties of the 
drug — the first being that methadone is 
longer-acting and withdrawal symptoms 
do not normally become evident for 24 
to 48 hours. Secondly, on a fixed dosage, 
the euphoric effects of taking meth-
adone quickly dissipate — the patient is 
able to funct ion in his normal or usual 
state. In a program where methadone is 
administered daily in a f ixed dosage, the 
patient is soon no longer euphor ic , and 
is in his state of usual normality. He is 
not faced wi th the imminent pressure of 
withdrawal symptoms if he shows up 
daily for his medicat ion. Cross-tolerance 
deve lops be tween me thadone and 
short-lasting opiates, l imi t ing the user's 
ability to get " h i g h " if he tries heroin 
again. Wi th the blockage of euphoria, 
and delayed wi thdrawal , the cycle of 
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euphoria to normality to withdrawal is 
thus el iminated. The patient remains in 
his normal environment but wi th sig-
nificant changes — he no longer has to 
concentrate his at tent ion on drug-
seeking behavior; he is able to funct ion 
normally and thus able to become em-
ployed; he is able to re-establish normal 
social contacts, and family relations; and 
his medical health is no longer markedly 
endangered. '^ Furthermore, he has a-
vailable to h im, through his maintenance 
program, assistance for the increased 
anxiety which can be anticipated f rom a 
patient whose defense mechanisms have 
been d isrupted by dependency on 
drugs, and who must now re-establish 
an effective set of coping mechanisms.'" 
It is clear that the accomplishment of 
all of the objectives does not occur 
quickly. In cooperative patients, one can 
expect them to occur wi th in six months 
to a year after gett ing into a program. 
Some persons may require less and cer-
tain persons more t ime in the program, 
depending on the assessment of other 
factors besides the condi t ion ing factors. 
Over a per iod of t ime the patient, having 
established a stable way of l i fe, has ex-
t inguished all of his condi t ioned re-
sponses, because of his exposure to his 
previous envi ronment , even if it is of dif-
ferent quality and di f ferent quantity. 
There is, however, one area to which 
he is not exposed whi le on the program, 
and that is the experience of withdrawal 
symptoms. Usually one sees a crisis in a 
patient on a maintenance program via 
the occurrence of a situation which 
simulates withdrawal symptoms. This is 
characterized by a severe f lu-l ike illness 
wi th diarrhea, coryza, etc, and an occa-
sional anxiety crisis. When wi thdrawing 
patients f rom a methadone program, 
one has to face a final stage in the condi-
t ion ing cycle. A very slow and gradual 
reduction is mandatory, since wi th-
drawal symptoms f rom methadone are 
much longer lasting and have greater 
severity than the shorter term opiates. 
This is probably because the dosage that 
the patient takes in the maintenance 
program is equivalently much higher 
than he wou ld have used in illegal 
opiates. A sudden stoppage of meth-
adone is usually accompanied by acute 
symptoms, becoming marked by 72 
hours, and only slowly receding over a 
two-week per iod. Even wi th slow wi th-
drawal, symptoms such as diarrhea, may 
occur, lasting several m o n t h s . O n oc-
casion hospitalization is necessary for 
the final stages of the withdrawal cycle. 
Addit ional support ive psychotherapy is 
necessary at this point , but knowing 
precisely when to do this remains to be 
determined. 
The Wor ld Health Expert Committee's 
def in i t ion of methadone maintenance 
the continuing daily oral administration of 
methadone, under adequate medical 
supervision, with the dose being adjusted 
to prevent: 
a) the occurrence of abstinent phenome-
non; 
b) to suppress partially or completely any 
preoccupation with the taking of drugs 
of a morphine type; 
c) to establish a sufficient degree of toler-
ance or cross-tolerance to blunt or 
suppress the effects of such agent."" 
It appears to me that this def in i t ion is 
inadequate in that it includes two types 
of programs which are similar, but have 
significant differences. The first of these 
types of programs is very closely t ied to 
the concept of substituting a legal narcot-
ic addict ion pattern for an illegal narcot-
ic addict ion pattern. Here, the patient is 
being dispensed methadone in a sup-
posed fixed dose, but the control over 
when and how it is taken is entrusted to 
the user himself. The patient tends to 
take the methadone in relationship to 
previous condi t ioned st imul i ; to take a 
varying dose, often wi th the deliberate 
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intent ion to get " h i g h " ; and then to an-
t icipate wi thdrawal symptoms much 
sooner than they wou ld occur physiolog-
ically. In examin ing some narcot ic 
treatment programs in England, I noted 
that methadone was often used as a pre-
cise substitute for hero in , and was given 
by inject ion even on a six-to-eight-hour 
cycle. Patients in these circumstances 
complained of feel ing "s ick" near the 
end of the cycle, and despite the ab-
sence of marked withdrawal symptoms, 
drug-seeking behavior was ini t iated. ' " 
Methadone, when given in a bl ind in-
ject ion, has been found to be indist in-
guishable f rom heroin or di laudid.^" It 
has the capacity to produce the previ-
ously experienced narcotic euphoria. 
Any narcotic taken by mouth wi l l pro-
duce less of this, but given in widely var-
ying doses, eg, f rom zero one day to 200 
mg the next, euphoria can be expected 
to occur. Methadone is not an ideal drug 
of abuse because tolerance to the 
euphoric effects apparently occurs more 
rapidly, perhaps because of the long-
acting effect of the drug. However, 
methadone has the advantage of being 
cheap, readily available, and somewhat 
freer of the impurit ies and other risks 
that usually accompany the ingestion of 
illegal drugs. Al though it wou ld seem 
that some degree of f lexibi l i ty is appro-
priate in any methadone maintenance 
program, the greater contro l a patient 
has of the drug , and the greater the 
number of patients that have this con-
t ro l , the more the drug wi l l be used to 
attempt to re-establish addict ion pat-
terns, in as close a facsimile to the or igi-
nal as is possible. Al though no hard fig-
ures are available on this po int , it is 
nevertheless a very real and significant 
compl icat ion. 
If a patient were to receive methadone 
in association wi th life confl icts, and ex-
perienced euphoria regularly as a result 
of taking methadone, he wou ld not have 
el iminated the narcotic cycle of hero in, 
but altered its length of operat ion. I re-
emphasize the importance of withdrawal 
symptoms, but still maintain the critical 
importance of the euphoric component . 
No clinic wou ld deliberately set out to 
establish doses of methadone that 
wou ld vary f rom as litt le as zero to an 
indefinite maximum, in a somewhat ran-
dom manner. I clearly recognize that be-
cause of the length of t ime it takes to 
develop withdrawal symptoms, such a 
schedule could be arranged, but it 
wou ld produce in the patient the effects 
that he previously experienced in his i l-
legal narcotic habit. Yet, a number of 
programs make the rather obvious mis-
take of prematurely giving control of the 
t ime, and thus, indirectly, the dosage of 
the methadone that the patient takes, by 
prescribing the drug either in tablet form 
or by lett ing the patient take the drug 
away f rom the clinic wi th h im. If this is 
permi t ted, it is reasonable to expect that 
an indeterminate percentage of patients 
wi l l uti l ize the methadone to replace the 
narcotic cycle previously experienced, 
i n c l u d i n g e u p h o r i a . Pat ients on 
methadone do not lose their desire to be 
" h i g h " , and their fond memories of their 
" h i g h " experiences. They generally lose 
pre-occupation wi th the desire to get 
" h i g h " . They lose this because they are 
not gett ing " h i g h " wi th methadone, and 
partly because methadone has been es-
tablished in their minds as an agent 
which wi l l prevent them f rom becoming 
" h i g h " if they used an illegal drug such 
as hero in. They are thereby able to con-
centrate on the dimensions of an effec-
tive rehabil i tation program. 
In o the rwords , it seems necessary, for 
an effective methadone maintenance 
program, to establish a dependency 
upon a hospital or clinic setting that is 
maintained by the necessity of returning 
daily for the methadone, in order to 
avoid facing severe withdrawal symp-
toms. Thus, wi th the patient coming to 
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the clinic daily, control led dosage re-
mains in the hands of the physician, 
p e r m i t t i n g a rap id e l i m i n a t i o n of 
euphor ia, and establishing a setting 
under which the el iminat ion of the con-
d i t ion ing factors can occur. Periodic 
urinalyses, regular contact wi th the pa-
t ient, and more formal ized involvement 
such as group therapy give an adequate 
assessment of the patient's cooperat ion. 
W i t h w e l l - m o t i v a t e d pa t i en t s , t he 
maintenance dosage level of methadone 
need not be as high as was originally 
thought." ' ' Probably a dosage of 50 mg 
per day completely eliminates the dys-
phoric effects of being off hero in , and 
keeps the patient in a relatively settled 
state of health and mind. Dosages even 
at this level develop a cross-tolerance, 
b locking the average dose of street 
strength heroin. A lower dose allows for 
a shorter and easier withdrawal f rom 
methadone at the t ime when the patient 
should give up his dependency on the 
hospital or cl inic. 
Some patients' experimentat ions wi th 
heroin appear to require the use of 
higher doses of methadone. This wou ld 
be justif ied to stabilize the patient in a 
pattern of non-abuse of other narcotics. 
The use of b l ind dosages allows reduc-
t ion in total amount of methadone at an 
earlier stage, wi th less concentrat ion in 
contact between the physician and pa-
tient on the dosage of methadone per 
se. Questions remain about precise dos-
ages and precise patterns of using these 
drugs, whether the dosages relate more 
directly to the patient's previous length 
and intensity of involvement wi th nar-
cotics, or to the patient's personality. At 
least it should be eventually related to 
these factors, rather than to the person-
ality of the therapist. To deviate f rom this 
program, at least init ial ly, is to establish 
the opportuni ty for a significant number 
of patients to produce a substitute addic-
t ion , not only in the physiological sense, 
but also in the psychological sense. I 
suggest it wou ld make the eventual re-
moval of the patient f rom the program 
more di f f icul t , interfere wi th his present 
funct ion ing, and may even lead to an in-
crease in periodic heroin usage.^" 
Summary 
Hence, a maintenance methadone 
program is more than maintaining a pa-
tient on methadone, but is the util ization 
of methadone by continual administra-
t ion , in relatively f ixed dosages, ob-
tained on a daily basis, under supervi-
s ion, together wi th the assistance of an 
organized cl inic, to aid in effective 
changes in the patient's personality and 
coping mechanisms, in improving his 
social situation — thus al lowing eventu-
ally for the el imination of the condi t ion-
ing factors which maintain his involve-
ment in narcotics. The dependency 
upon the hospital for methadone may 
become eventually unwelcome and an 
aid in the total rehabil i tation of the ad-
dict to a funct ioning member of society 
at or near his original potent ial , before 
involvement in narcotics. 
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